On Wednesday, the Algerian Minister of Pharmaceutical Industry, Ouacim Kouidri, met with his Omani counterpart, Dr. Hilal bin Ali bin Hilal Alsabti, to discuss potential collaboration in the pharmaceutical sector. This meeting took place during a high-level Omani ministerial delegation’s visit to Algeria.
The Omani minister, who toured several public and private pharmaceutical production facilities, expressed his admiration for the progress made in Algeria’s pharmaceutical industry. He highlighted the synergy between the public and private sectors and the high quality of Algerian pharmaceutical products.
The discussions led to concrete proposals. Oman is considering importing Algerian pharmaceutical products and opening its market to Algerian investors. In return, the Sultanate proposed establishing factories in Algeria in partnership with Omani operators.
Minister Kouidri emphasized the achievements of Algeria’s pharmaceutical sector, which now meets 75% of domestic demand. He specifically mentioned the full-process production of anticancer drugs, vaccines, and insulin by the Saidal Group. Algeria also plans to start producing raw materials for anticancer drugs in the near future.
This meeting follows the October summit between the leaders of both countries, which aimed to strengthen economic ties. In this context, Algeria expressed its readiness to establish partnerships and share expertise and knowledge with Oman in the pharmaceutical field.
